Search results
Hush-money trial was Trump's to lose. Here’s why he did
BBC via Yahoo News· 1 hour agoMr Blanche hammered these points. In his closing argument, he called Cohen the “GLOAT” - the...
Jury Finds Trump Guilty on All 34 Counts in His New York Criminal Trial
The Dispatch via Yahoo News· 2 hours agoBut, under New York state law, if the defendant is alleged to have cooked the books in an effort to...
Donald Trump to Speak on Friday in Wake of His Conviction
New York Times· 2 hours agoIn the Florida case in which he was charged with obstruction of justice and unlawfully holding onto...
Ivanka Trump, Donald Trump's sons react to guilty verdict in hush money trial
ABC News· 21 minutes agoIvanka Trump delivered a brief -- and indirect -- social media post late Thursday in the wake of her...
Philadelphia Inquirer: As he becomes a convicted felon, yet another ignominious first for Donald...
Billings Gazette· 1 hour agoDonald Trump’s criminal conviction in a Manhattan courtroom on all 34 counts should not surprise...
Self-styled ‘Joker’ made pillow with face of ex he ‘tried to kill’, court told
Press Association News via AOL· 1 hour agoThe jury in the trial of man who styled himself on The Joker have been shown a photograph of a...
Philadelphia Inquirer: As he becomes a convicted felon, yet another ignominious first for Donald...
Martinsville Bulletin· 1 hour agoDonald Trump’s criminal conviction in a Manhattan courtroom on all 34 counts should not surprise...
Opinion | ‘Trump Is Now a Felon, and That Will Matter’: 7 Writers on the Guilty Verdict
New York Times· 4 hours agoIn this special feature, Times Opinion writers reflect on this extraordinary development in American...
Everything you should know about Donald Trump's conviction in his hush money trial
KMBC-TV Kansas City· 1 hour agoTrump angrily denounced the trial as a “disgrace,” telling reporters he’s an “innocent man.” The big...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 50 minutes agoScientists have hailed the drug, called lorlatinib, for its “off the charts” results after a trial...